Quetiapine
Quoted from the FDA label. Product labels differ by manufacturer and change over time; confirm against the label for the product you are using. Not yet reviewed by a ClinDose pharmacist.
Dosing in kidney impairment
Renal Impairment Clinical experience with quetiapine in patients with renal impairment is limited [see Clinical Pharmacology ].
Dosing in liver impairment
Dose Modifications in Hepatically Impaired Patients Patients with hepatic impairment should be started on 25 mg/day. The dose should be increased daily in increments of 25 mg/day - 50 mg/day to an effective dose, depending on the clinical response and tolerability of the patient.
Preparation and administration
Important Administration Instructions Quetiapine tablets, USP can be taken with or without food.